相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
Nicola Amodio et al.
Oncotarget (2015)
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells
Nicola Amodio et al.
CELL CYCLE (2013)
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
Emanuela Leone et al.
CLINICAL CANCER RESEARCH (2013)
From Target Therapy to miRNA Therapeutics of Human Multiple Myeloma: Theoretical and Technological Issues in the Evolving Scenario
Marco Rossi et al.
CURRENT DRUG TARGETS (2013)
Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma
Nicola Amodio et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease
Marco Rossi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma
Maria Teresa Di Martino et al.
ONCOTARGET (2013)
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
Maria T. Di Martino et al.
CLINICAL CANCER RESEARCH (2012)
MicroRNAs in the Pathobiology of Multiple Myeloma
Marta Lionetti et al.
CURRENT CANCER DRUG TARGETS (2012)
Molecular Targets for the Treatment of Multiple Myeloma
Marco Rossi et al.
CURRENT CANCER DRUG TARGETS (2012)
Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
P. Tagliaferri et al.
CURRENT CANCER DRUG TARGETS (2012)
Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma
P. Tassone et al.
CURRENT CANCER DRUG TARGETS (2012)
Macromolecular therapeutics in cancer treatment: The EPR effect and beyond
Hiroshi Maeda
JOURNAL OF CONTROLLED RELEASE (2012)
Latest advances and current challenges in the treatment of multiple myeloma
Anuj Mahindra et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N. Amodio et al.
CELL DEATH & DISEASE (2012)
Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA
Mark Mackiewicz et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
T. Calimeri et al.
LEUKEMIA (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response
Y-H Lee et al.
ONCOGENE (2011)
MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma
Pasqualino de Antonellis et al.
PLOS ONE (2011)
Capture of MicroRNA-Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor Signaling
Ashish Lal et al.
PLOS GENETICS (2011)
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Jason F. Wiggins et al.
CANCER RESEARCH (2010)
Epigenetic inactivation of the miR-34a in hematological malignancies
C. S. Chim et al.
CARCINOGENESIS (2010)
The miR-34 family in cancer and apoptosis
H. Hermeking
CELL DEATH AND DIFFERENTIATION (2010)
Oligonucleotide delivery in cancer therapy
Giuseppe De Rosa et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
Adam D. Judge et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
MicroRNAs as potential cancer therapeutics
P Trang et al.
ONCOGENE (2009)
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Qing Ji et al.
PLOS ONE (2009)
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
p53-mediated activation of miRNA34 candidate tumor-suppressor genes
Guido T. Bommer et al.
CURRENT BIOLOGY (2007)
Targeting the phosphatidylinositol 3-kinase pathway in multiple myeloma
Hashem Younes et al.
CLINICAL CANCER RESEARCH (2007)
Differential regulation of microRNAs by p53 revealed by massively parallel Sequencing -: miR-34a is a p53 target that induces apoptosis and G1-arrest
Valery Tarasov et al.
CELL CYCLE (2007)
A microRNA component of the p53 tumour suppressor network
Lin He et al.
NATURE (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis
Nina Raver-Shapira et al.
MOLECULAR CELL (2007)
Instability of miRNA and cDNAs derivatives in RNA preparations
Valia Bravo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
A SCID-hu in vivo model of human Waldenstrom macroglobulinemia
P Tassone et al.
BLOOD (2005)
A clinically relevant SCID-hu in vivo model of human multiple myeloma
P Tassone et al.
BLOOD (2005)
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
LP Lim et al.
NATURE (2005)
Prediction of mammalian microRNA targets
BP Lewis et al.
CELL (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures
SC Semple et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
分享论文
